208 related articles for article (PubMed ID: 23008511)
1. Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification.
Douglas G; Van Kampen E; Hale AB; McNeill E; Patel J; Crabtree MJ; Ali Z; Hoerr RA; Alp NJ; Channon KM
Eur Heart J; 2013 Nov; 34(43):3378-88. PubMed ID: 23008511
[TBL] [Abstract][Full Text] [Related]
2. PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design.
Holy EW; Jakob P; Eickner T; Camici GG; Beer JH; Akhmedov A; Sternberg K; Schmitz KP; Lüscher TF; Tanner FC
Eur Heart J; 2014 Mar; 35(12):808-20. PubMed ID: 24334406
[TBL] [Abstract][Full Text] [Related]
3. INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.
Burzotta F; Brancati MF; Trani C; Porto I; Tommasino A; De Maria G; Niccoli G; Leone AM; Coluccia V; Schiavoni G; Crea F
Trials; 2012 May; 13():55. PubMed ID: 22559260
[TBL] [Abstract][Full Text] [Related]
4. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin accelerates both neointimal coverage and re-endothelialization after sirolimus-eluting stent implantation in a porcine model: new findings from optical coherence tomography and pathology.
Wang TJ; Yang YJ; Xu B; Zhang Q; Jin C; Tang Y; Tian Y; Mintz GS
Circ J; 2012; 76(11):2561-71. PubMed ID: 22878407
[TBL] [Abstract][Full Text] [Related]
6. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
[TBL] [Abstract][Full Text] [Related]
7. Stents Eluting 6-Mercaptopurine Reduce Neointima Formation and Inflammation while Enhancing Strut Coverage in Rabbits.
Ruiter MS; van Tiel CM; Doornbos A; Marinković G; Strang AC; Attevelt NJ; de Waard V; de Winter RJ; Steendam R; de Vries CJ
PLoS One; 2015; 10(9):e0138459. PubMed ID: 26389595
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries.
Suna G; Wojakowski W; Lynch M; Barallobre-Barreiro J; Yin X; Mayr U; Baig F; Lu R; Fava M; Hayward R; Molenaar C; White SJ; Roleder T; Milewski KP; Gasior P; Buszman PP; Buszman P; Jahangiri M; Shanahan CM; Hill J; Mayr M
Circulation; 2018 Jan; 137(2):166-183. PubMed ID: 29030347
[TBL] [Abstract][Full Text] [Related]
9. Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study.
Lehtinen T; Airaksinen KE; Ylitalo A; Karjalainen PP
Int J Cardiovasc Imaging; 2012 Dec; 28(8):1859-66. PubMed ID: 22362097
[TBL] [Abstract][Full Text] [Related]
10. Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor.
Ma X; Hibbert B; Dhaliwal B; Seibert T; Chen YX; Zhao X; O'Brien ER
Cardiovasc Res; 2010 May; 86(2):338-45. PubMed ID: 20167573
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of stents coated with antibody against CD105 on preventing restenosis and thrombosis in minipigs].
Cui S; Lü SZ; Chen YD; He GX; Yan HB; Meng LJ; Liu H; Song XT; Jin ZN; Ge CJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jul; 38(7):648-51. PubMed ID: 21055292
[TBL] [Abstract][Full Text] [Related]
12. Effect of a Novel Stent on Re-Endothelialization, Platelet Adhesion, and Neointimal Formation.
Tang H; Wang Q; Wang X; Zhou J; Zhu M; Qiao T; Liu C; Mao C; Zhou M
J Atheroscler Thromb; 2016; 23(1):67-80. PubMed ID: 26347048
[TBL] [Abstract][Full Text] [Related]
13. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
Zhao FH; Chen YD; Jin ZN; Lu SZ
Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
[TBL] [Abstract][Full Text] [Related]
14. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
[TBL] [Abstract][Full Text] [Related]
15. Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization.
Kleinedler JJ; Foley JD; Orchard EA; Dugas TR
J Control Release; 2012 Apr; 159(1):27-33. PubMed ID: 22269665
[TBL] [Abstract][Full Text] [Related]
16. Long-term vascular responses to Resolute® and Xience V® polymer-based drug-eluting stents in a rabbit model of atherosclerosis.
Hoymans VY; VAN Dyck CJ; Haine SE; Frederix G; Fransen E; Timmermans JP; Vrints CJ
J Interv Cardiol; 2014 Aug; 27(4):381-90. PubMed ID: 24815761
[TBL] [Abstract][Full Text] [Related]
17. Differential healing after sirolimus, paclitaxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor gamma agonists: requirement for mTOR/Akt2 in PPARgamma activation.
Finn AV; John M; Nakazawa G; Polavarapu R; Karmali V; Xu X; Cheng Q; Davis T; Raghunathan C; Acampado E; Ezell T; Lajoie S; Eppihimer M; Kolodgie FD; Virmani R; Gold HK
Circ Res; 2009 Nov; 105(10):1003-12. PubMed ID: 19797172
[TBL] [Abstract][Full Text] [Related]
18. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
[TBL] [Abstract][Full Text] [Related]
19. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation.
Lim WH; Seo WW; Choe W; Kang CK; Park J; Cho HJ; Kyeong S; Hur J; Yang HM; Cho HJ; Lee YS; Kim HS
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2798-805. PubMed ID: 22015656
[TBL] [Abstract][Full Text] [Related]
20. The importance of the endothelium in atherothrombosis and coronary stenting.
Otsuka F; Finn AV; Yazdani SK; Nakano M; Kolodgie FD; Virmani R
Nat Rev Cardiol; 2012 May; 9(8):439-53. PubMed ID: 22614618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
